Related Experiment Video
Updated: Jun 23, 2025
07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
3.7K
Clinical Presentation and Therapy of Ventricular Septal Defect
Nikolaus A Haas1, David J Driscoll2, Silke Rickert-Sperling3
1Department of Pediatric Cardiology and Intensive Care, Ludwig Maximilians University, Munich, Germany. Nikolaus.haas@med.uni-muenchen.de.
Advances in Experimental Medicine and Biology
|June 17, 2024
Summary
Ventricular septal defects (VSDs) are common congenital heart conditions, affecting 1.5-3.5 per 1000 live births. These defects represent 20% of all congenital cardiac anomalies and show no gender preference.
Area of Science:
- Cardiology
- Pediatrics
- Congenital Heart Disease
Background:
- Ventricular septal defects (VSDs) are a significant subset of congenital cardiac defects.
- Understanding the prevalence and demographics of VSDs is crucial for public health planning and resource allocation.
Purpose of the Study:
- To summarize the epidemiological characteristics of ventricular septal defects.
- To establish the incidence rate of VSDs in live births.
- To determine the proportion of congenital cardiac defects attributed to VSDs.
Main Methods:
- Epidemiological data analysis.
- Review of live birth statistics.
- Compilation of congenital cardiac defect registries.
Main Results:
- VSDs occur in 1.5 to 3.5 per 1000 live births.
- Ventricular septal defects account for 20% of all congenital cardiac defects.
- No significant gender predominance was observed in the incidence of VSDs.
Conclusions:
- VSDs are a common congenital heart anomaly with a consistent incidence across live births.
- The prevalence data underscores the importance of VSDs within the spectrum of congenital heart disease.
- The lack of gender predominance suggests multifactorial etiology or equal susceptibility.
Related Concept Videos
01:28Esophageal Perforation-II: Clinical Manifestations and Management
54
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
54
01:28Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
01:30Pulmonary Hypertension: Classification and Pathogenesis
168
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
168
01:24Cystic Fibrosis: Management
154
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
154
01:26Esophageal Strictures-II: Clinical Features and Management
61
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
61
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
197
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
197